UAlberta scientists have created molecular nanomachines that work in living cells. The work is expected to make inroads on improved disease detection and drug delivery in the future.
University of Alberta scientists have pulled into the lead in a race to use nanomachines for improved disease detection and drug delivery in patients.
In a study published in Nature Communications, the researchers describe the creation of synthetic DNA motors in living cells. The process - previously only successful in test tubes - demonstrates how DNA motors can be used to accomplish specific and focused biological functions in live cells.
"This is really big because of the diverse potential applications," says Chris Le, Canada Research Chair and a distinguished university professor of laboratory medicine & pathology. "One outcome of this will be to provide better and earlier disease detection. Another is the controllable release of targeted drug molecules within patients, resulting in fewer side effects."
The team, which also includes Hongquan Zhang, an assistant professor of laboratory medicine & pathology, postdoctoral fellow Hanyong Peng, and Xing-Fang Li, a professor of laboratory medicine & pathology, created the nanomachine from compartments made up of DNA enzyme molecules and substrates. "This nanomachine has the required fuels, DNA tracks, and a molecular switch," says Zhang.
For the study, it was 'tuned' to detect a specific microRNA sequence found in breast cancer cells. When it came into contact with the targeted molecules, the DNA motor was turned on and produced fluorescence as part of a reaction. The researchers were able to monitor the fluorescence, detecting which cells were cancerous . Le believes the findings show great promise for the early diagnosis of disease.
"We want to be able to detect cancer or disease markers in very minute amounts before the disease gets out of hand. That way physicians can attack it very early," says Le. "The trace amount of the target molecules that may be missed by other techniques can now be detected with this one."
In addition to the potential for improved disease diagnosis, the researchers say DNA motors could also be used for precision drug delivery in patients. Conventional targeted drug therapy delivers medicine to a selectively targeted site of action, yet it still affects a large number of molecules that are not diseased. With the DNA motor, the team says a drug payload can be delivered and then released only when triggered by disease specific molecules.
"You still have some drug molecules going to the normal cells - you can't avoid that," says Le. "Using the DNA motor, we hope to deliver the drug into the cells in an inactive form. Only when the DNA motor encounters the targeted molecules can the drug then be released to be active."
While the team used a breast cancer marker for the study, the aim now is to expand the work to examine a wider range of other disease markers. Further testing on the nanomachines is needed to better understand the full range of capabilities for drug delivery.
Meet our partners in innovation
The Canada Research Chairs Program (CRCP) stands at the centre of a national strategy to make Canada one of the world's top countries in research and development. In 2000, the Government of Canada created a permanent program to establish 2,000 research professorships-Canada Research Chairs-in eligible degree-granting institutions across the country. The CRCP invests approximately $265 million per year to attract and retain some of the world's most accomplished and promising minds.
At the Canadian Institutes of Health Research (CIHR), research has the power to change lives. As Canada's health research investment agency, CIHR collaborates with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
Natural Sciences and Engineering Research Council of Canada (NSERC) invests over $1 billion each year in natural sciences and engineering research in Canada. Its investments deliver discoveries-valuable world-firsts in knowledge claimed by a brain trust of over 11,000 professors. The investments enable partnerships and collaborations that connect industry with discoveries and the people behind them. Researcher-industry partnerships established by NSERC help inform R&D, solve scale-up challenges, and reduce the risks of developing high-potential technology.
Alberta Health is the ministry that sets policy, legislation and standards for the health system in Alberta. The ministry allocates health funding and administers provincial programs such as the Alberta Health Care Insurance Plan and provides expertise on communicable disease control.
Alberta Innovates delivers 21st century solutions to the most compelling challenges Albertans face. Building on our province's strengths in environment, energy, health, food, fibre and emerging technology sectors, we are working with our partners to diversify Alberta's economy, improve our environmental performance and enhance our well-being.